Superselective Arterial Hyaluronidase Thrombolysis Is Not an Effective Treatment for Hyaluronic Acid-Induced Retinal Artery Occlusion: Study in a Rabbit Model

Plast Reconstr Surg. 2021 Jan 1;147(1):69-75. doi: 10.1097/PRS.0000000000007449.

Abstract

Background: Worldwide application of hyaluronic acid has brought about severe complications, including central retinal arterial occlusion, which leads to a deleterious effect on vision. The current study explored the efficacy of superselective arterial hyaluronidase thrombolysis in rabbit retinal artery occlusion induced by hyaluronic acid.

Methods: Occlusion of the internal/external ophthalmic artery in New Zealand White rabbits was induced with superselective injection of hyaluronic acid. Superselective subtraction angiography and fundus examination were conducted to confirm and evaluate the artery embolism. After 30 minutes of embolism, hyaluronidase was injected in the occluded artery through superselective arterial intubation.

Results: Compared with preoperative and contralateral eyes, the postoperative eyes showed the symptoms of central retinal arterial occlusion and embolization, confirmed by digital subtraction angiography. After intraarterial hyaluronidase thrombolysis, the embolization failed to dissolve as shown on funduscopic and angiographic examinations.

Conclusions: Superselective ophthalmic artery intervention could accurately and successfully establish the animal models of retinal artery occlusion induced by hyaluronic acid. The precise occlusion site of the retinal artery and complete embolism were confirmed by ophthalmologic examinations. Intraarterial hyaluronidase thrombolysis might not be an effective method to treat retinal artery occlusion induced by hyaluronic acid.

MeSH terms

  • Angiography, Digital Subtraction
  • Animals
  • Cosmetic Techniques / adverse effects*
  • Dermal Fillers / administration & dosage
  • Dermal Fillers / adverse effects*
  • Disease Models, Animal
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / adverse effects
  • Hyaluronoglucosaminidase / administration & dosage*
  • Injections, Intra-Arterial
  • Injections, Subcutaneous / adverse effects
  • Ophthalmic Artery / diagnostic imaging
  • Ophthalmic Artery / drug effects
  • Rabbits
  • Retinal Artery Occlusion / chemically induced
  • Retinal Artery Occlusion / diagnosis
  • Retinal Artery Occlusion / drug therapy*
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / methods*
  • Treatment Outcome
  • Urokinase-Type Plasminogen Activator

Substances

  • Dermal Fillers
  • Hyaluronic Acid
  • Hyaluronoglucosaminidase
  • Urokinase-Type Plasminogen Activator